MedPath
NMPA Approval

Gliclazide Sustained-release Tablets

国药准字H20254382

May 27, 2025

Drug Information

格列齐特缓释片

片剂

60mg

化学药品

May 27, 2025

Company Information

Applicant Company

山东省菏泽市开发区长江东路现代医药港中央商务区028

Manufacturing Company

北京市通州区工业开发区广源东街16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.